We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Denied Sovaldi Patents in India, Paving Way for Generic Competition
Gilead Denied Sovaldi Patents in India, Paving Way for Generic Competition
Unauthorized knock-offs of Gilead’s pricey blockbuster hepatitis C therapy, Sovaldi, may soon hit the market in India after the government refused to grant it patent protection.